文献速递胃肠外科

美国机器人对比腹腔镜胃切除术治疗腺癌:倾向性评分匹配分析11,173例患者的肿瘤学充分性

Robotic versus laparoscopic gastrectomy for adenocarcinoma in the US: a propensity score-matching analysis of 11,173 patients on oncological adequacy.
PubMed 文献 · Surg Endosc · 2023-11-09

基于美国国家癌症数据库2010至2019年11,173例微创胃癌根治术患者,其中腹腔镜组8320例、机器人组2853例,经1:1倾向性评分匹配后,机器人组淋巴结清扫≥16枚的比例显著高于腹腔镜组(63.5% vs 60.4%,p=0.01),而阴性切缘率、延长住院率、90天死亡率、术后化疗率及总生存率两组无显著差异。

要点

  • 匹配前机器人组淋巴结清扫≥16枚比例高于腹腔镜组(63.5% vs 57.1%,p<0.0001)。
  • 匹配后机器人组淋巴结清扫≥16枚比例仍高于腹腔镜组(63.5% vs 60.4%,p=0.01)。
  • 匹配后两组阴性切缘率、延长住院率、90天死亡率、术后化疗率及总生存率无显著差异。

核心结论

  • 该倾向性评分匹配分析显示,与腹腔镜胃切除术相比,机器人胃切除术与更高的充分淋巴结清扫率相关;两组阴性切缘率、延长住院率、术后化疗率、90天死亡率及总生存率相似,提示机器人手术是可与腹腔镜手术相媲美、甚至可能更优的手术方式。

研究设计与样本

  • 利用美国国家癌症数据库识别2010年至2019年因腺癌行胃切除术的患者,进行机器人胃切除术(RG)与腹腔镜胃切除术(LG)的倾向性评分匹配分析,主要结局为淋巴结清扫≥16枚和手术切缘。

主要发现

  • 共11,173例患者接受微创手术治疗胃腺癌,其中8320例行LG,2853例行RG。
  • 未匹配队列中,RG组充分淋巴结清扫率高于LG组(63.5% vs 57.1%,p<0.0001)。
  • 未匹配队列中,RG组阴性切缘率高于LG组(93.8% vs 91.9%,p<0.001)。
  • 未匹配队列中,RG组延长住院率低于LG组(26.0% vs 29.6%,p<0.001),90天死亡率低于LG组(3.7% vs 5.0%,p<0.0001)。
  • 未匹配队列中,RG组5年总生存率优于LG组(56% vs 54%,p=0.03);匹配后两组阴性切缘率、延长住院率、90天死亡率、术后化疗率及总生存率无显著差异。

关键数值与推荐

  • 匹配后RG组充分淋巴结清扫率为63.5%,LG组为60.4%(p=0.01)。

临床怎么用

  • 原文未据此给出推荐。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

INTRODUCTION: Surgery remains the cornerstone treatment for gastric cancer. Previous studies have reported better lymphadenectomy with minimally invasive approaches. There is a paucity of data comparing robotic and laparoscopic gastrectomy in the US. Herein, we examined whether oncological adequacy differs between laparoscopic and robotic approaches. METHODS: The National Cancer Database was utilized to identify patients who underwent gastrectomy for adenocarcinoma between 2010 and 2019. A propensity score-matching analysis between robotic gastrectomy (RG) versus laparoscopic gastrectomy (LG) was performed. The primary outcomes were lymphadenectomy ≥ 16 nodes and surgical margins. RESULTS: A total of 11,173 patients underwent minimally invasive surgery for gastric adenocarcinoma between 2010 and 2019. Of those 8320 underwent LG and 2853 RG. Comparing the unmatched cohorts, RG was associated with a higher rate of adequate lymphadenectomy (63.5% vs 57.1%, p < .0.0001), higher rate of negative margins (93.8% vs 91.9%, p < 0.001), lower rate of prolonged length of stay (26.0% vs 29.6%, p < .0.001), lower 90-day mortality (3.7% vs 5.0%, p < 0.0001), and a better 5-year overall survival (OS) (56% vs 54%, p = 0.03). A propensity score-matching cohort with a 1:1 ratio was created utilizing the variables associated with lymphadenectomy ≥ 16 nodes. The matched analysis revealed that the rate of adequate lymphadenectomy was significantly higher for RG compared to LG, 63.5% vs 60.4% (p = 0.01), respectively. There was no longer a significant difference between RG and LG regarding the rate of negative margins, prolonged length of stay, 90-day mortality, rate of receipt of postoperative chemotherapy, and OS. CONCLUSIONS: This propensity score-matching analysis with a large US cohort shows that RG was associated with a higher rate of adequate lymphadenectomy compared to LR. RG and LG had a similar rate of negative margins, prolonged length of stay, receipt of postoperative chemotherapy, 90-day mortality, and OS, suggesting that RG is a comparable surgical approach, if not superior to LG.

来源:Surg Endosc,查看原文。版权归原作者所有。

引用

  1. Maegawa FB, Patel AD, Patel SG, et al. Robotic versus laparoscopic gastrectomy for adenocarcinoma in the US: a propensity score-matching analysis of 11,173 patients on oncological adequacy. Surg Endosc. 2023. PMID: 37943334. doi:10.1007/s00464-023-10519-7

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。